Metformin Use and Survival of Patients With Pancreatic Cancer: A Cautionary Lesson [Gastrointestinal Cancer]
Conclusion
Our findings did not suggest the benefit of metformin use after patients are diagnosed with PDAC. We highlight the importance of patient selection and appropriate statistical analytical methods when studying medication exposure and cancer survival.
Source: Journal of Clinical Oncology - Category: Cancer & Oncology Authors: Chaiteerakij, Petersen, Bamlet, Chaffee, Zhen, Burch, Leof, Roberts, Oberg Tags: Prognostic Studies, Epidemiology, Statistics in Oncology Gastrointestinal Cancer Source Type: research
More News: Adenocarcinoma | Cancer | Cancer & Oncology | Clinical Trials | Diabetes | Endocrinology | Epidemiology | Fortamet | Gastroenterology | Lessons | Metformin | Pancreas | Pancreatic Cancer | Statistics | Study